Related Experiment Videos
Angiotensin converting enzyme inhibition and calcium channel blockade as primary antihypertensive therapy
Insights
Seeking the best antihypertensive drugs, this study proposes age-and renin-level-based selection. Angiotensin converting enzyme inhibitors or beta-blockers for younger, high-renin patients and calcium antagonists for older, low-renin patients can normalize blood pressure effectively.
Area of Science:
- Cardiology
- Pharmacology
- Hypertension Research
Background:
- Large antihypertensive trials focus on blood pressure control for reducing cardiovascular events.
- The ideal antihypertensive aims for efficacy without adverse effects.
- Essential hypertension involves age-dependent changes in cardiovascular regulation and cellular calcium homeostasis.
Purpose of the Study:
- To propose an alternative treatment concept for essential hypertension based on patient characteristics.
- To identify optimal drug classes for specific patient subgroups.
- To improve blood pressure normalization and minimize side effects.
Main Methods:
- Review of studies on cellular membrane and calcium derangements in hypertension.
- Analysis of age-dependent cardiovascular regulation and peripheral vasoconstriction.
- Development of an age-and renin-level-based drug selection strategy.
Main Results:
- An age-oriented, two-way drug selection strategy is proposed.
- Angiotensin converting enzyme inhibitors or beta-blockers are suggested for younger, high-renin patients.
- Calcium antagonists are recommended for older, low-renin or Black patients, potentially replacing diuretics.
Conclusions:
- This age-oriented approach can normalize blood pressure in approximately 80% of essential hypertension patients without adverse effects.
- The strategy aids in optimizing drug combinations for difficult-to-treat cases.
- Tailored antihypertensive therapy based on patient profiles enhances treatment outcomes.
Abstract:
Recent large-scale antihypertensive treatment trials primarily emphasize the quality of blood pressure control for reduction of cerebrovascular accidents as well as for myocardial infarction, practically irrespective of the type of drug used. Therefore, the best drug that normalizes blood pressure without adverse effects should be sought. On the basis of studies demonstrating cellular membrane and calcium homoeostatic derangements, and an age-dependent transition of overall cardiovascular regulation and peripheral vasoconstrictor forces during the course of essential hypertension, an alternative treatment concept is proposed: angiotensin converting enzyme inhibitors or beta-blockers can primarily be used in younger patients and those with a high renin, while calcium antagonists are used in place of diuretics in older, low-renin or black patients. Age-oriented two-way drug selection enables normalization of blood pressure without untoward effects in about 80% of patients with essential hypertension, and helps to optimize drug combinations in those patients who are difficult to treat.